A daily pill called daraxonrasib combined with chemotherapy made tumours undetectable in one in 12 patients with advanced pancreatic cancer in a trial of 61 participants. Tumours stopped growing in nearly all participants, marking what experts call a major breakthrough for the disease. Although doct